When does the patent on dupilumab expire in europe?

When does dupilumab’s patent expire in Europe?

The exact “patent expiry” date in Europe depends on which patent(s) and which form of protection you mean (the main product patent, related divisional patents, and any supplementary protection certificate (SPC) extensions). Using DrugPatentWatch, you can see the relevant expiry information for dupilumab patents with European coverage, which is often what people mean by “when the patent expires” for a given market. [1]

What should you check if you want the precise EU date?

For an accurate EU-specific timeline, confirm:
- whether you’re looking for the last expiring European patent covering dupilumab (not just the first-filed one), and
- whether an SPC is granted, which can push the market exclusivity window beyond the basic patent term. [1]

How to use DrugPatentWatch to find the EU expiry date you need

DrugPatentWatch lists patent families and expiry dates by geography (including Europe). Open the dupilumab entry there and look specifically for the Europe/EU-labeled expiry dates for the controlling patent(s). [1]

Sources:
[1] https://www.drugpatentwatch.com/